Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartphone app could help people with down syndrome remember their lives

NCT ID NCT07008989

Symptom relief Sponsor: Boston College Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study tests whether a smartphone app called HippoCamera can help people with Down syndrome remember specific details from their daily lives. Participants record and replay events using the app, which uses an algorithm to select which memories to revisit. The goal is to see if this digital memory aid improves the richness and specificity of autobiographical memory.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a digital memory prosthetic called HippoCamera, a smartphone app that records and replays daily events using a research-based algorithm
What this could lead to
If it works, this could offer a simple, non-drug way to improve autobiographical memory and independence in people with Down syndrome.
What could go wrong
This is a small, early-stage study with 40 participants, and the app may not improve memory enough to make a real difference in daily life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

15 to 35 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of Down syndrome * Daily access to a smart phone * The ability to create and replay memories using HippoCamera with limited support from a guardian * Informed consent obtained from parent or guardian (or participant, if legally independent) * Informed verbal assent obtained from participant * Ability to comprehend instructions, denoted by parent/guardian acknowledgment * English as a primary written and spoken language * Normal or corrected-to-normal vision and hearing * All races/ethnicities and socio-economic statuses Exclusion Criteria: * Autism * Non-native speaker of English (acquired after the age of 5)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hippocamera are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Down syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hippocamera Memory replay

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Boston College ONLINE STUDY

    RECRUITING

    Chestnut Hill, Massachusetts, 02467, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.